Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction - CNBC

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.

By: CNBC

Oct 31 2024
0
0 Views

Biogen on Wednesday reported third-quarter revenue and adjusted earnings that topped expectations while raising its full-year profit guidance, as sales of its breakthrough Alzheimer's drug, Leqembi, … [+1992 chars]

Jobs report on eve of election will be among the most distorted in years - The Associated Press

VW faces strikes over 'Pandora's box' of plant closures as profits plunge - Reuters

Private job creation totaled a stunning 233,000 in October, far more than expected, ADP says - CNBC

Vini Jr, Ballon d'Or drama shows it's only as important as we make it - ESPN

Panthers trade Diontae Johnson to Baltimore - Panthers.com

Yankees, facing elimination, change lineup for G4 - ESPN

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network

all our websites